HK Stock MarketDetailed Quotes

00512 GRANDPHARMA

Watchlist
  • 4.320
  • +0.060+1.41%
Not Open Apr 26 16:08 CST
15.33BMarket Cap8.15P/E (TTM)

GRANDPHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

GRANDPHARMA Earnings Date

Currency: HKD

Period

FY2023 Annual Report

Mar 19, 2024

Revenue(YoY)

10.53B

+10.12%
EPS(YoY)

0.54

-8.69%
Analyst Rating

Strong Buy

Apr 28, 2024

GRANDPHARMA Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: HKD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 13.620B--
--2024/FY-- / 12.055B--
Mar 19, 20242023/FY10.530B / 10.605B--
Mar 22, 20232022/FY9.562B / 9.635B--
Mar 17, 20222021/FY8.598B / 8.367B--
Mar 17, 20212020/FY6.353B / 6.353B--
Mar 27, 20202019/FY6.591B / 7.162B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 13.620B--
--2024/FY-- / 12.055B--
Mar 19, 20242023/FY10.530B / 10.605B--
Mar 22, 20232022/FY9.562B / 9.635B--
Mar 17, 20222021/FY8.598B / 8.367B--
Mar 17, 20212020/FY6.353B / 6.353B--
Mar 27, 20202019/FY6.591B / 7.162B--
--------
--------
--------

Unlock Free Earnings Estimates

GRANDPHARMA Earnings Reports

  • GRANDPHARMA: Annual Report 2023

    Apr 26 10:30 ET

  • GRANDPHARMA: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023

    Mar 19 18:01 ET

  • GRANDPHARMA: DATE OF BOARD MEETING

    Mar 7 04:40 ET

  • GRANDPHARMA: INTERIM REPORT 2023

    Sep 26, 2023 04:54 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 28, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    HK
    Overall
    Symbol
    Latest Price
    %Chg